These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 4739655

  • 1. HL-A antigens in solid tumors.
    Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW.
    Cancer Res; 1973 Apr; 33(4):648-50. PubMed ID: 4739655
    [No Abstract] [Full Text] [Related]

  • 2. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M, Mickey MR, Terasaki PI.
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract] [Full Text] [Related]

  • 3. HL-A and lymphoid tumors.
    Dick FR, Fortuny I, Theologides A, Greally J, Wood N, Yunis EJ.
    Cancer Res; 1972 Dec; 32(12):2608-11. PubMed ID: 4509228
    [No Abstract] [Full Text] [Related]

  • 4. HL-A antigens on cells isolated from malignant and nonmalignant lymph nodes.
    Naeim F, Stoddard A, Smith GS, Walford RL.
    Tissue Antigens; 1974 Dec; 4(2):166-71. PubMed ID: 4600072
    [No Abstract] [Full Text] [Related]

  • 5. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M, Kinoshita K.
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract] [Full Text] [Related]

  • 6. Immunomorphologic changes in regional lymph nodes associated with cancer.
    Brynes RK, Hunter RL, Vellios F.
    Arch Pathol Lab Med; 1983 May; 107(5):217-21. PubMed ID: 6687668
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxicity of lymphocytes to established cultures of human tumors: evidences for specificity.
    Sinkovics JG, Tebbi K, Cabiness JR.
    Natl Cancer Inst Monogr; 1973 Jun; 37():9-18. PubMed ID: 4123456
    [No Abstract] [Full Text] [Related]

  • 8. [Studies on changes in lymphocyte HL-A antigens during the course of malignant diseases].
    Májský A, Chudomel V, Jakoubová J, Fiŝerová V, Hyánková M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975 Jun; 102(1):20-8. PubMed ID: 50965
    [Abstract] [Full Text] [Related]

  • 9. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P, Demaille A, Adenis L.
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract] [Full Text] [Related]

  • 10. The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
    Adair SJ, Carr TM, Fink MJ, Slingluff CL, Hogan KT.
    J Immunother; 2008 Jan; 31(1):7-17. PubMed ID: 18157007
    [Abstract] [Full Text] [Related]

  • 11. [6 cases of second primary neoplasms].
    Ardiles A, Aldunate C, Lagos M, Larraín P, Martínez C, Olivares R.
    Rev Med Chil; 1990 Nov; 118(11):1291-3. PubMed ID: 1967110
    [No Abstract] [Full Text] [Related]

  • 12. Tuberculin reactions in patients with Hodgkin's disease.
    Glińska H, Pawlicki M.
    Pol Med J; 1970 Nov; 9(3):670-5. PubMed ID: 5468684
    [No Abstract] [Full Text] [Related]

  • 13. HL-A antigens and hematologic malignancy.
    Miller WV.
    Arch Intern Med; 1974 Mar; 133(3):397-9. PubMed ID: 4521322
    [No Abstract] [Full Text] [Related]

  • 14. Alterations of monocyte function in neoplastic diseases.
    Unger SW, Bernhard MI, Pace R, Wanebo HJ.
    Surg Forum; 1979 Mar; 30():142-4. PubMed ID: 538578
    [No Abstract] [Full Text] [Related]

  • 15. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET, Ossorio RC, Brosman SA.
    Int J Cancer; 1974 Sep 15; 14(3):326-34. PubMed ID: 4477556
    [No Abstract] [Full Text] [Related]

  • 16. Levels of Ia-like antigen bearing lymphocytes in patients with solid primary tumors.
    Cordiali-Fei P, Natali PG, Pecci G, Pellegrino MA, Ferrone S.
    J Clin Lab Immunol; 1981 Nov 15; 6(3):197-9. PubMed ID: 6951050
    [Abstract] [Full Text] [Related]

  • 17. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET.
    Cancer Res; 1972 May 15; 32(5):960-7. PubMed ID: 4502173
    [No Abstract] [Full Text] [Related]

  • 18. Histocompatibility antigens in bovine lymphosarcoma. A preliminary study.
    Takashima I, Olson C.
    Ann Rech Vet; 1978 May 15; 9(4):821-3. PubMed ID: 382967
    [No Abstract] [Full Text] [Related]

  • 19. Case-control study of Hodgkin's disease. II. Herpesvirus group antibody titers and HL-A type.
    Henderson BE, Dworsky R, Menck H, Alena B, Henle W, Henle G, Terasaki P, Newell GR, Rawlings W, Kinnear BK.
    J Natl Cancer Inst; 1973 Nov 15; 51(5):1443-7. PubMed ID: 4357759
    [No Abstract] [Full Text] [Related]

  • 20. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I, Hellström KE.
    Johns Hopkins Med J Suppl; 1974 Nov 15; 3():37-50. PubMed ID: 4608238
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.